BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.01 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Notes Payables (2017)

Updated

BioXcel Therapeutics' Notes Payables was $371,000 in Q4 2017.

Analysis

BioXcel Therapeutics (BTAIQ) Notes Payables (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 371,000.00
API Access

BioXcel Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY